MLFP
TCRT icon

MPS Loria Financial Planners’s Alaunos Therapeutics TCRT Stock Holding History

MPS Loria Financial Planners’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3
Closed -$1K – 508
2021
Q1 		$1K Hold
3
– – ﹤0.01% 536
2020
Q4 		$1K Hold
3
– – ﹤0.01% 584
2020
Q3 		$1K Hold
3
– – ﹤0.01% 313
2020
Q2 		$2K Buy
+3
New +$1.34K ﹤0.01% 305
2017
Q3 		– Sell
-12
Closed -$10K – 295
2017
Q2 		$10K Buy
+12
New +$11.8K 0.01% 295

Other funds holding TCRT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

MPS Loria Financial Planners's TCRT Position: Q2 2021 in Review

MPS Loria Financial Planners sold out of Alaunos Therapeutics (TCRT) in Q2 2021, closing a stake of 3 shares — an estimated $1K sold.

MPS Loria Financial Planners first reported a position in TCRT in Q2 2017 and held it in 5 quarters. The position peaked at $10K in Q2 2017. 155 funds tracked by Wall St. Rank hold TCRT as of Q2 2021.

  • MPS Loria Financial Planners reported no remaining Alaunos Therapeutics position as of Q2 2021 after selling out during the quarter.
  • MPS Loria Financial Planners sold 3 Alaunos Therapeutics shares in Q2 2021, an estimated $1K.
  • MPS Loria Financial Planners first reported a position in Alaunos Therapeutics in Q2 2017 and held it in 5 quarters.
  • MPS Loria Financial Planners's Alaunos Therapeutics position peaked at $10K in Q2 2017.
  • 155 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2021.

Based on MPS Loria Financial Planners's 13F filing for Q2 2021, filed 20 Jul 2021.